Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marjolein van Ballegooijen"'
Autor:
Suzette M Matthijsse, Steffie K Naber, Jan A C Hontelez, Roel Bakker, Marjolein van Ballegooijen, Iris Lansdorp-Vogelaar, Inge M C M de Kok, Harry J de Koning, Joost van Rosmalen, Sake J de Vlas
Publikováno v:
PLoS ONE, Vol 13, Iss 9, p e0202924 (2018)
BACKGROUND:Human papillomavirus (HPV) vaccination and the implementation of primary HPV screening in the Netherlands will lead to a lower cervical disease burden. For evaluation and further improvement of prevention, it is important to estimate the m
Externí odkaz:
https://doaj.org/article/3b82aed01b914272a04c306f9fcda0c3
Autor:
S Lucas Goede, Linda Rabeneck, Marjolein van Ballegooijen, Ann G Zauber, Lawrence F Paszat, Jeffrey S Hoch, Jean H E Yong, Sonja Kroep, Jill Tinmouth, Iris Lansdorp-Vogelaar
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0172864 (2017)
BACKGROUND:The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is considering switching from biennial guaiac fecal occult blood test (gFOBT) screening between age 50-74 years to the more sensitive, but also less spe
Externí odkaz:
https://doaj.org/article/71e8c5880de84218a8ea982978a449b8
Autor:
Steffie K Naber, Suzette M Matthijsse, Kirsten Rozemeijer, Corine Penning, Inge M C M de Kok, Marjolein van Ballegooijen
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0145548 (2016)
Vaccination against the oncogenic human papillomavirus (HPV) types 16 and 18 will reduce the prevalence of these types, thereby also reducing cervical cancer risk in unvaccinated women. This (measurable) herd effect will be limited at first, but is e
Externí odkaz:
https://doaj.org/article/45345d27348749c3a4fa155db5c7931b
Autor:
Suzette M Matthijsse, Joost van Rosmalen, Jan A C Hontelez, Roel Bakker, Inge M C M de Kok, Marjolein van Ballegooijen, Sake J de Vlas
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0116618 (2015)
BACKGROUND: Knowledge of the natural history of human papillomavirus (HPV), in particular the role of immunity, is crucial in estimating the (cost-) effectiveness of HPV vaccination and cervical cancer screening strategies, because naturally acquired
Externí odkaz:
https://doaj.org/article/b5e0d27d910b4d139f232f37e78a5e36
Autor:
Robine Hofman, Esther W de Bekker-Grob, Jan Hendrik Richardus, Harry J de Koning, Marjolein van Ballegooijen, Ida J Korfage
Publikováno v:
PLoS ONE, Vol 9, Iss 8, p e104772 (2014)
To assess how girls' preferences have changed almost 3 years after the much debated start of the human papillomavirus (HPV) vaccination program.A discrete choice experiment (DCE) was conducted among girls aged 11-15 years who were invited, or were no
Externí odkaz:
https://doaj.org/article/69b84f8f475c42af9e8eeac20afe45a5
Autor:
Jeffrey S Hoch, Jean H E Yong, S. Lucas Goede, Marjolein van Ballegooijen, Linda Rabeneck, Jill Tinmouth, Iris Lansdorp-Vogelaar, Lawrence Paszat, Ann G. Zauber, Sonja Kroep
Publikováno v:
PloS one, vol 12, iss 3
PLoS ONE, Vol 12, Iss 3, p e0172864 (2017)
PLoS One (print), 12(3):e0172864. Public Library of Science
PLoS ONE
PLoS ONE, Vol 12, Iss 3, p e0172864 (2017)
PLoS One (print), 12(3):e0172864. Public Library of Science
PLoS ONE
Background The ColonCancerCheck screening program for colorectal cancer (CRC) in Ontario, Canada, is considering switching from biennial guaiac fecal occult blood test (gFOBT) screening between age 50±74 years to the more sensitive, but also less sp
Autor:
Suzette M. Matthijsse, Kirsten Rozemeijer, Steffie K. Naber, Inge M.C.M. de Kok, Corine Penning, Marjolein van Ballegooijen
Publikováno v:
PLoS One (print), 11(1). Public Library of Science
PLoS ONE, Vol 11, Iss 1, p e0145548 (2016)
PLoS ONE
PLoS ONE, Vol 11, Iss 1, p e0145548 (2016)
PLoS ONE
Background Vaccination against the oncogenic human papillomavirus (HPV) types 16 and 18 will reduce the prevalence of these types, thereby also reducing cervical cancer risk in unvaccinated women. This (measurable) herd effect will be limited at firs
Autor:
Ida J. Korfage, Esther W. de Bekker-Grob, Harry J. de Koning, Jan Hendrik Richardus, Robine Hofman, Marjolein van Ballegooijen
Publikováno v:
PLoS ONE
PLoS ONE, Vol 9, Iss 8, p e104772 (2014)
PLoS One (print), 9(8). Public Library of Science
PLoS ONE, Vol 9, Iss 8, p e104772 (2014)
PLoS One (print), 9(8). Public Library of Science
Objectives: To assess how girls' preferences have changed almost 3 years after the much debated start of the human papillomavirus (HPV) vaccination program. Methods: A discrete choice experiment (DCE) was conducted among girls aged 11-15 years who we
Autor:
Jan A. C. Hontelez, Sake J. de Vlas, Inge M.C.M. de Kok, Marjolein van Ballegooijen, Roel Bakker, Joost van Rosmalen, Suzette M. Matthijsse
Publikováno v:
PLoS ONE, Vol 10, Iss 2, p e0116618 (2015)
PLoS One, 10
PLoS ONE
PLoS One, 10, 2
PLoS One (print), 10(2). Public Library of Science
PLoS One, 10
PLoS ONE
PLoS One, 10, 2
PLoS One (print), 10(2). Public Library of Science
Contains fulltext : 154245.PDF (Publisher’s version ) (Open Access) BACKGROUND: Knowledge of the natural history of human papillomavirus (HPV), in particular the role of immunity, is crucial in estimating the (cost-) effectiveness of HPV vaccinatio